# Investigation of the Gut Microbiome and Statin Response

> **NCT04098003** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Sony Tuteja** · enrollment: 62 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04098003
- **Lead sponsor:** Sony Tuteja
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-06
- **Primary completion:** 2025-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04098003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04098003, "Investigation of the Gut Microbiome and Statin Response". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04098003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*